TXLNG
Basic information
Region (hg38): X:16786432-16844519
Previous symbols: [ "CXorf15" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TXLNG gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 20 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 20 | 3 | 1 |
Variants in TXLNG
This is a list of pathogenic ClinVar variants found in the TXLNG region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-16786500-G-T | not specified | Uncertain significance (Oct 26, 2022) | ||
X-16786536-G-A | not specified | Uncertain significance (May 28, 2024) | ||
X-16818583-G-A | not specified | Uncertain significance (Nov 18, 2022) | ||
X-16818646-C-G | not specified | Uncertain significance (Mar 14, 2023) | ||
X-16818683-G-A | not specified | Uncertain significance (Sep 27, 2022) | ||
X-16818725-G-C | not specified | Uncertain significance (Mar 29, 2022) | ||
X-16818742-G-A | not specified | Likely benign (Jan 19, 2024) | ||
X-16818861-C-A | not specified | Uncertain significance (Oct 05, 2022) | ||
X-16820187-C-G | not specified | Uncertain significance (Mar 14, 2023) | ||
X-16820208-A-G | not specified | Uncertain significance (Jun 07, 2024) | ||
X-16828155-T-C | not specified | Uncertain significance (Aug 15, 2023) | ||
X-16829598-G-A | not specified | Uncertain significance (Jun 18, 2024) | ||
X-16829634-A-G | not specified | Uncertain significance (Dec 13, 2021) | ||
X-16829741-C-G | not specified | Uncertain significance (Jan 04, 2022) | ||
X-16832627-T-C | not specified | Uncertain significance (Oct 04, 2022) | ||
X-16832646-T-G | not specified | Uncertain significance (Apr 24, 2024) | ||
X-16832668-G-T | not specified | Uncertain significance (Mar 04, 2024) | ||
X-16832725-C-G | not specified | Uncertain significance (Mar 01, 2024) | ||
X-16834296-C-T | not specified | Uncertain significance (Jan 09, 2024) | ||
X-16837609-A-G | not specified | Uncertain significance (Mar 07, 2023) | ||
X-16837662-A-G | not specified | Uncertain significance (Nov 10, 2022) | ||
X-16841437-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
X-16841458-C-G | not specified | Uncertain significance (Jun 06, 2022) | ||
X-16841525-A-G | not specified | Uncertain significance (Jan 16, 2024) | ||
X-16841526-T-C | Likely benign (Feb 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TXLNG | protein_coding | protein_coding | ENST00000380122 | 10 | 58093 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.998 | 0.00155 | 122733 | 1 | 1 | 122735 | 0.00000815 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0863 | 181 | 184 | 0.982 | 0.0000141 | 3469 |
Missense in Polyphen | 19 | 40.629 | 0.46764 | 946 | ||
Synonymous | -0.497 | 81 | 75.5 | 1.07 | 0.00000625 | 960 |
Loss of Function | 4.02 | 0 | 18.8 | 0.00 | 0.00000149 | 327 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000255 | 0.00000895 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000252 | 0.000169 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in intracellular vesicle traffic. Inhibits ATF4-mediated transcription, possibly by dimerizing with ATF4 to form inactive dimers that cannot bind DNA. May be involved in regulating bone mass density through an ATF4-dependent pathway. May be involved in cell cycle progression. {ECO:0000269|PubMed:15911876, ECO:0000269|PubMed:18068885}.;
- Pathway
- Validated transcriptional targets of AP1 family members Fra1 and Fra2
(Consensus)
Recessive Scores
- pRec
- 0.118
Intolerance Scores
- loftool
- rvis_EVS
- 0.44
- rvis_percentile_EVS
- 77.8
Haploinsufficiency Scores
- pHI
- 0.801
- hipred
- Y
- hipred_score
- 0.592
- ghis
- 0.465
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Txlng
- Phenotype
- skeleton phenotype; normal phenotype;
Gene ontology
- Biological process
- cell cycle;regulation of cell cycle process;regulation of bone mineralization;regulation of cell cycle
- Cellular component
- cytosol;nuclear membrane
- Molecular function
- syntaxin binding;protein heterodimerization activity